• OPEN AN ACCOUNT
Indian Indices
Nifty
23,350.40 159.75
(0.69%)
Sensex
76,905.51 557.45
( 0.73%)
Bank Nifty
50,593.55 530.70
( 1.06%)
Nifty IT
36,702.80 26.15
( 0.07%)
Global Indices
Nasdaq
42,006.35 32.02
(0.08%)
Dow Jones
5,627.00 -47.50
(-0.84%)
Hang Seng
37,730.70 -21.18
(-0.06%)
Nikkei 225
8,643.68 -58.31
(-0.67%)
Forex
USD-INR
86.33 -0.10
(-0.11%)
EUR-INR
93.80 -0.47
(-0.50%)
GBP-INR
112.00 -0.20
(-0.18%)
JPY-INR
0.58 0.00
(0.47%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
282.5572901
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
38.43
34057.28
EPS(TTM)
Face Value()
Div & Yield %
70.94
2
1.89
 

As on: Mar 21, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,726.50 99.80 17148 38.43
Stock Price Details
Open Price() 2,667.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,880.45
Today's Low () 2,633.10
52-Week High () 3485.75
152-Week Low () 2049.75
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 1.89
Eps 70.94
Book Value 282.5572901
Market Cap (.Cr) 34,057.28
Face Value 2
Market Lot 1
AGM Date Jul
Book Closure Date
ISIN No. INE031B01049


News
Piramal Pharma Ltd Spurts 3.8%
Ajanta Pharma Ltd - Intimation For Capacity Addition Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Ajanta Pharma Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
Ajanta Pharma Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
Godfrey Phillips India Ltd leads losers in 'A' group
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Ajanta Pharma Ltd - Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Ajanta Pharma Ltd - Ajanta Pharma Limited - Updates
Thomas Cook (India) Ltd leads losers in 'A' group
Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions
More
Corporate Details
Incoporation Year   : 1979
Chairman : Mannalal B Agrawal
Bussiness Group : Indian Private
Registered Office
Ajanta Pharma Ltd
Ajanta House,
Charkop Kandivli (W),
Mumbai,
Maharashtra-400067
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-66061000/1204/1203
Fax:91-22-66061200/1300
Fax:91-22-66317458
E-Mail : info@ajantapharma.com; investorgrievance@ajantapha
URL : http://www.ajantapharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • CNX 500
  • CNX Pharma
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi